24/12/2024
Big news for patients with Obstructive Sleep Apnea and obesity: Zepbound has now been approved based on results from the SURMOUNT-OSA phase 3 study. Click the link to learn more. 👉 https://bit.ly/4gSj9ip
The approval was based on data from the double-blind, phase 3 SURMOUNT-OSA study.